Biotech Articles
Publish Your Research Online
Get Recognition - International Audience

Request for an Author Account   |   Login   |   Submit Article

Proteasomes - The Dooms Day Chamber For Proteins

BY: Sandhya Anand | Category: Others | Submitted: 2011-06-10 02:58:14
       No Photo
Article Summary: "Proteasomes are involved in protein degradation and a variety of other cellular processes. The article brings out the roles and importance of proteasomes..."

Share with Facebook Share with Linkedin Share with Twitter Share with Pinterest Email this article

Proteasomes are multiunit protein complexes involved in protein degradation. The mechanism is of importance since they play a key role in selectively degrading non functional and damaged proteins. The complex is preent in nucleus as well as cytosol of all eukryotic cells. A typical human cell contains about 30000 proteasome complexes each weighing about 700 kDa.

The structure

The 26 S proteasome complex is made of 3 major subunits.
1. a 20 S core complex and
2. Two 19S subunits (regulatory particles)
20S core complex is composed of two units each of 14 different polypeptide chains. The polypeptides are arranged in groups of 7 with 7 alpha and 7 beta proteins. They form four ring-like structures stacked one above the other forming a cylinder. The alpha units form the outer rings and the beta rings form the interior. There is a narrow cavity

The 19S subunits are identical in nature and form the ends of the 20S cylindrical core complex. Each subunit in turn is composed of 18 different polypeptides which are different from that of core particle. Six of the chains are ATPases which help in ATP hydrolysis. The subunits also have ubiquitin-recognizing sites.


Proteasomes are involved in degradation of endogenous proteins such as transcription factors, cyclins, proteins damaged by translation errors, viral and other pathogenic proteins etc.

Three beta subunits act as proteases on different substrates.
a. Act on tyrosine or Phenylalanine residues at C' end. Similar to Chymotrypsin in activity.
b. Act on arginine or lysine at P1 end like trypsin.
c. The third one prefers glutamate or any acidic aminoacids at the P1 position.

Major cell processes such as cell division, apoptosis, differentiation and development involve proteasomal degradation. Proteasome mediated degradation of cyclins control the progress of cell cycle through different stages. Cyclins are responsible for activation of cyclin dependent kinases. Similarly, proteasomal subunits are inactivated by glycosylation when the extracellular levels of glucose are high thus controlling the proteolysis inside the cell.

The 19S regulatory subunits recognize the proteins which are polyubiquitinated, remove ubiquitin and unfold proteins for degradation. The ubiquitin-mediated protein degradation is involved in many important processes such as intracellular signal transduction, regulation of gene expression, embryonic development, apoptosis, and control of cell division. Ubquitination is also a marking strategy for proteins which are misfolded or mistranslated for degradation. The 19S subunits are thus involved in multitasking and therefore are energy-dependent (ATP-requiring) for their functioning.

The 2004 Noble Prize in Chemistry was shared by Ciechanover, Hershko and Rose for the discovery of ubiquitin mediated protein degradation. With that further research in protein degradation has grown rapidly and had unearthed further roles of proteasomes.

The 19S subunit has been studies in detail and found to have multicatalytic nature. They serve as checking point to allow the proteins into the 20S complex selectively for degradation.


They are found in higher vertebrates and are involved with immune system. In these proteasomes, the regular catalytic subunits are replaced by three homologous beta subunits. They also produce peptides which can alter the response of TCD8+ cells to viral proteins. They are constitutively expressed in the tissues involved in immune function. Gamma interferons(IFN) and Tumor Necrosis factor (TNF-alpha) and cytokines are known to induce the production of immunoproteasomes in other cells. They are found in association with TAP (Transporter associated with Antigen Presentation).

The viral proteins are labeled with MHC-I molecules. They fuse with the cell membrance which results in activation of cytotoxic T cells to initiate the immune response.

Difference from standard proteasomes

a.) They also differ from standard proteasomes in the speed of maturation process. Generally, proteasomes don't get activated until the 20S structure is assembled. The catalytic subunits are kept inactive till the amino terminal propeptide is removed and an active threonine residue is added. The immunoproteasomes are found to be four times faster than standard ones in maturation.

b.) Immunoproteasomes are relatively less stable when compared to standard proteasomes. However, in case of viral infections in presence of increased cytokine release has been found to accelerate the degradation of standard proteasomes so that immunoproteasomes are abundant.
The immunoproteasomes as such deserve further researches to explore the role in normal cells, regulation and the role in other tissues with little or no immunogenic function.

About Author / Additional Info:

Search this site & forums
Share this article with friends:

Share with Facebook Share with Linkedin Share with Twitter Share with Pinterest Email this article

More Social Bookmarks (Digg etc..)

Comments on this article: (0 comments so far)

Comment By Comment

Leave a Comment   |   Article Views: 3357

Additional Articles:

•   IPad vs Microsoft Surface Pro

•   Asthma Tips That Are Easy to Try

•   The Modern Technology For the Industrial Centrifuge

•   Nanobiotechnology in Cardiovascular Disorders

Latest Articles in "Others" category:
•   Biotechnology, Its Techniques and Human Health

•   Techniques of Biotechnology

•   Nanomedicine and Disease Treatment

•   Biotechnology and Livestock

•   Bioinformatics: Combination of Biotechnology and Information Technology

•   Gene Patenting and Its Uses

•   Polymerase Chain Reaction: A Technique of Biotechnology

•   Pharmacogenomics: Benefits and Barriers

•   Human Genome Project: Ethical and Legal Issues

•   Plant and Animal Tissue Culture: Procedure, Benefits and Limitations

•   Therapeutics and Biotechnology

•   Biotechnology: A Revolutionary Field and Biotech Challenges

•   Recombinant DNA Technology

•   Environment and Biotechnology

•   Biosensors: Role in Biotechnology

•   Human Insulin and Recombinant DNA Technology

•   Biotechnology and Its Applications

•   Genetic Engineering and its Methods

•   Types of Gene Mutations - Diseases Caused By Gene Mutation

Important Disclaimer: All articles on this website are for general information only and is not a professional or experts advice. We do not own any responsibility for correctness or authenticity of the information presented in this article, or any loss or injury resulting from it. We do not endorse these articles, we are neither affiliated with the authors of these articles nor responsible for their content. Please see our disclaimer section for complete terms.
Page copy protected against web site content infringement by Copyscape
Copyright © 2010 - Do not copy articles from this website.

Agriculture Bioinformatics Applications Biotech Products Biotech Research
Biology Careers College/Edu DNA Environmental Biotech
Genetics Healthcare Industry News Issues Nanotechnology
Others Stem Cells Press Release Toxicology  

  |   Disclaimer/Privacy/TOS   |   Submission Guidelines   |   Contact Us